NCT00212901View on ClinicalTrials.gov

High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

September 30, 2006

Conditions
Diabetic Kidney Disease
Interventions
DRUG

High dose ACE-I vs ARB

Trial Locations (1)

K1H 7W9

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER